The incidence rate of insulin-dependent (Type I) diabetes mellitus is bimodal: one peak occurs close to puberty, and the other in the fifth decade. To evaluate possible differences in these forms of the disease, we examined the clinical, biochemical, autoimmune, and genetic features of 82 children and adolescents (1.3 to 18.2 years old) and 44 adults (20.0 to 55.8 years old) when they presented with Type I diabetes. The mean (+/- SEM) duration of symptoms before diagnosis was longer in the adults (7.5 +/- 1.0 vs. 3.9 +/- 0.4 weeks; P less than 0.001), and their serum C-peptide concentrations at diagnosis were higher (0.29 +/- 0.03 vs. 0.17 +/- 0.01 nmol per liter; P less than 0.001), suggesting that they had more residual beta-cell function. There were no significant differences between the two groups in sex ratio, blood glucose levels, hemoglobin A1 values, degree of metabolic decompensation, or frequency of Type I diabetes in first-degree relatives. Thirty-four of 80 children tested (42.5 percent) were positive for insulin autoantibodies, as compared with only 1 of 26 adults (3.8 percent; P less than 0.001). However, the frequencies of islet-cell autoantibodies were similar in the adults and children (conventional autoantibodies, both 81 percent; complement-fixing autoantibodies, 46.2 percent and 60 percent). More children than adults were heterozygous for both HLA-Dw3/4 antigens (26.6 percent vs. 9.8 percent; P less than 0.05) and HLA-DR3/4 antigens (36.6 percent vs. 12.5 percent; P less than 0.05). We conclude that Type I diabetes that begins in adulthood is characterized by a longer symptomatic period before diagnosis, better preservation of residual beta-cell function, and lower frequencies of insulin autoantibodies and HLA-D3/D4 heterozygosity than Type I diabetes that begins in childhood or adolescence.
Source Information
Department of Pediatrics, University of Oulu, Finland.
This article has been cited by other articles:
de Leiva, A., Mauricio, D., Corcoy, R.
(2007). Diabetes-Related Autoantibodies and Gestational Diabetes. Diabetes Care
30: S127-S133
[Full Text]
Sherry, N. A., Tsai, E. B., Herold, K. C.
(2005). Natural History of {beta}-Cell Function in Type 1 Diabetes. Diabetes
54: S32-S39
[Abstract][Full Text]
Palmer, J. P., Hampe, C. S., Chiu, H., Goel, A., Brooks-Worrell, B. M.
(2005). Is Latent Autoimmune Diabetes in Adults Distinct From Type 1 Diabetes or Just Type 1 Diabetes at an Older Age?. Diabetes
54: S62-S67
[Abstract][Full Text]
Murao, S., Makino, H., Kaino, Y., Konoue, E., Ohashi, J., Kida, K., Fujii, Y., Shimizu, I., Kawasaki, E., Fujiyama, M., Kondo, S., Tanaka, K., Tarumi, Y., Seto, I., Kato, K., Ohno, K., Kusunoki, Y., Ebisui, O., Takada, Y., Tanabe, K., Takemoto, K., Onuma, H., Nishimiya, T., Osawa, H.
(2004). Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes in Japanese Patients. Diabetes
53: 2684-2690
[Abstract][Full Text]
Ortqvist, E., Bjork, E., Wallensteen, M., Ludvigsson, J., Aman, J., Johansson, C., Forsander, G., Lindgren, F., Berglund, L., Bengtsson, M., Berne, C., Persson, B., Karlsson, F. A.
(2004). Temporary Preservation of {beta}-Cell Function by Diazoxide Treatment in Childhood Type 1 Diabetes. Diabetes Care
27: 2191-2197
[Abstract][Full Text]
Larger, E., Rakotoaminina, B., Eddouks, M., Timsit, J., Boitard, C., Assan, R., Burcelin, R., Robert, J.-J.
(2004). Normal Insulin Sensitivity During the Late Preclinical Stage of Type 1 Diabetes. Diabetes Care
27: 1842-1843
[Full Text]
Hosszufalusi, N., Vatay, A., Rajczy, K., Prohaszka, Z., Pozsonyi, E., Horvath, L., Grosz, A., Gero, L., Madacsy, L., Romics, L., Karadi, I., Fust, G., Panczel, P.
(2003). Similar Genetic Features and Different Islet Cell Autoantibody Pattern of Latent Autoimmune Diabetes in Adults (LADA) Compared With Adult-Onset Type 1 Diabetes With Rapid Progression. Diabetes Care
26: 452-457
[Abstract][Full Text]
Stenstrom, G., Berger, B., Borg, H., Fernlund, P., Dorman, J. S., Sundkvist, G.
(2002). HLA-DQ Genotypes in Classic Type 1 Diabetes and in Latent Autoimmune Diabetes of the Adult. Am J Epidemiol
156: 787-796
[Abstract][Full Text]
Weets, I., Siraux, V., Daubresse, J.-C., De Leeuw, I. H., Fery, F., Keymeulen, B., Krzentowski, G., Letiexhe, M., Mathieu, C., Nobels, F., Rottiers, R., Scheen, A., Van Gaal, L., Schuit, F. C., Van Der Auwera, B., Rui, M., De Pauw, P., Kaufman, L., Gorus, F. K.
(2002). Relation between Disease Phenotype and HLA-DQ Genotype in Diabetic Patients Diagnosed in Early Adulthood. J. Clin. Endocrinol. Metab.
87: 2597-2605
[Abstract][Full Text]
Takeda, H., Kawasaki, E., Shimizu, I., Konoue, E., Fujiyama, M., Murao, S., Tanaka, K., Mori, K., Tarumi, Y., Seto, I., Fujii, Y., Kato, K., Kondo, S., Takada, Y., Kitsuki, N., Kaino, Y., Kida, K., Hashimoto, N., Yamane, Y., Yamawaki, T., Onuma, H., Nishimiya, T., Osawa, H., Saito, Y., Makino, H.
(2002). Clinical, Autoimmune, and Genetic Characteristics of Adult-Onset Diabetic Patients With GAD Autoantibodies in Japan (Ehime Study). Diabetes Care
25: 995-1001
[Abstract][Full Text]
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., Bluestone, J. A.
(2002). Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus. NEJM
346: 1692-1698
[Abstract][Full Text]
KAWASAKI, E., SERA, Y., ABIRU, N., YAMAUCHI, M., OZAKI, M., YAMAKAWA, K., ABE, T., UOTANI, S., YAMASAKI, H., YAMAGUCHI, Y., EGUCHI, K.
(2002). Distinct IA-2 Autoantibody Epitope Recognition between Childhood-Onset and Adult-Onset Type 1 Diabetes. Ann. N. Y. Acad. Sci.
958: 235-240
[Abstract][Full Text]
Kimpimaki, T., Kupila, A., Hamalainen, A.-M., Kukko, M., Kulmala, P., Savola, K., Simell, T., Keskinen, P., Ilonen, J., Simell, O., Knip, M.
(2001). The First Signs of {beta}-Cell Autoimmunity Appear in Infancy in Genetically Susceptible Children from the General Population: The Finnish Type 1 Diabetes Prediction and Prevention Study. J. Clin. Endocrinol. Metab.
86: 4782-4788
[Abstract][Full Text]
Pozzilli, P., Di Mario, U.
(2001). Autoimmune Diabetes Not Requiring Insulin at Diagnosis (Latent Autoimmune Diabetes of the Adult): Definition, characterization, and potential prevention. Diabetes Care
24: 1460-1467
[Abstract][Full Text]
Törn, C., Landin-Olsson, M., Lernmark, A., Palmer, J. P., Arnqvist, H. J., Blohmé, G., Lithner, F., Littorin, B., Nyström, L., Scherstén, B., Sundkvist, G., Wibell, L., Östman, J.
(2000). Prognostic Factors for the Course of {beta} Cell Function in Autoimmune Diabetes. J. Clin. Endocrinol. Metab.
85: 4619-4623
[Abstract][Full Text]
Obayashi, H., Hasegawa, G., Fukui, M., Kamiuchi, K., Kitamura, A., Ogata, M., Kanaitsuka, T., Shigeta, H., Kitagawa, Y., Nakano, K., Nishimura, M., Ohta, M., Nakamura, N.
(2000). Tumor Necrosis Factor Microsatellite Polymorphism Influences the Development of Insulin Dependency in Adult-Onset Diabetes Patients with the DRB1*1502-DQB1*0601 Allele and Anti-Glutamic Acid Decarboxylase Antibodies. J. Clin. Endocrinol. Metab.
85: 3348-3351
[Abstract][Full Text]
Bruno, G., Pagano, G., Faggiano, F., De Salvia, A., Merletti, F.
(2000). Effect of Sardinian heritage on risk and age at onset of type 1 diabetes: a demographic case-control study of Sardinian migrants. Int J Epidemiol
29: 532-535
[Abstract][Full Text]
Imagawa, A., Hanafusa, T., Miyagawa, J.-i., Matsuzawa, Y., The Osaka IDDM Study Group,
(2000). A Novel Subtype of Type 1 Diabetes Mellitus Characterized by a Rapid Onset and an Absence of Diabetes-Related Antibodies. NEJM
342: 301-307
[Abstract][Full Text]
